undefined

David Seligman

Workers' and consumer-rights attorney, executive director of the nonprofit Towards Justice, and candidate for Colorado Attorney General; provides legal analysis of forced arbitration and class-action waivers.

Top 3 podcasts with David Seligman

Ranked by the Snipd community
undefined
10 snips
May 15, 2025 • 44min

The Corporate Mole On The Supreme Court

David Seligman, the Executive Director of Toward Justice, dives into the transformative impact of the 1970s Powell memo on corporate power. He reveals how Justice Lewis Powell reshaped antitrust laws to favor corporations over worker rights. Discussion highlights include the ongoing effects of vertical restraints on healthcare and gig economies. Seligman also critiques the influence of Chicago school scholars on legal interpretations, illustrating how these historical shifts continue to affect economic equity and democracy in today's society.
undefined
Oct 13, 2025 • 39min

How Ticketmaster Made It Impossible To Sue Them

Join investigative reporter Luke Goldstein, who exposes Ticketmaster's hidden arbitration clauses, and David Seligman, a workers' rights attorney, as they unravel the ticketing giant's monopolistic practices. They discuss how recent changes strip consumers of their rights to sue and join class actions. Goldstein traces Live Nation's rise to power, while Seligman highlights the implications of forced arbitration, illustrating how it shields corporations from accountability. Together, they shed light on the urgent need for reform in this controversial industry.
undefined
Sep 23, 2025 • 1h 7min

On The Ground At The Antimonopoly Summit With Lina Khan, Sen. Chris Murphy, and More

Sen. Chris Murphy, a U.S. Senator from Connecticut, discusses the political landscape around media consolidation and the role of state attorneys general in protecting democracy. Rep. Becca Balint shares insights on antitrust messaging and mobilizing coalitions for effective change. Workers' rights attorney David Seligman emphasizes the need for state enforcement to challenge corporate consolidation. Lastly, Cost Plus Drugs CEO Alex Oshmyansky sheds light on the fight for pharmaceutical transparency against entrenched industry players.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app